Pular para o conteúdo principal
Ranking Invest

OMCL - Omnicell, Inc.

Segmento: HealthcareOmnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.

Análise Ranking Invest

Valuation estimado
$ 1.34 Bi
Valor de Mercado
$ 1.49 Bi
Sobrepreço (AV)+11.4%
IVR
0.90A companhia vale 0,90 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
IVR2
0.01O valuation alternativo equivale a 1% do valor de mercado da companhia.
MLL
0.01O lucro líquido dos controladores em 16 trimestres equivale a 1% do valor de mercado.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 1.29 Bi

Dívida Líquida

-$ 292.17 Mi

L4T

$ 39.08 Mi

MM4T

3.14%

Indicadores Básicos

ROE

3.03%

Índices de Previsibilidade

Receita Líquida

C0.06

Lucro

F3.31

Margem

F3.87

Índices de Tendência

Receita Líquida

D0.58

Lucro

B5.54

Margem

B5.67

Índices de Endividamento

DIV/PAT

-0.23

DIV/L4T

-7.48

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.